Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard
Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard
Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
69) M.V. <strong>Karamouzis</strong>, P.A. Konstantinopoulos & A.G. Papavassiliou: “ErbB/HER<br />
receptor family in breast cancer – The more we search the more we learn”, Ann<br />
Oncol, 19: 1020-1021, 2008.<br />
70) M.V. <strong>Karamouzis</strong>, A. Argiris, D. Raben & R. Ferris: “Head and Neck Cancer”,<br />
Lancet, 371: 1695-1709, 2008.<br />
71) G.P. Vandoros, T. Manolidis, M.V. <strong>Karamouzis</strong>, M. Gkermpesi, M.<br />
Lambropoulou, A.G. Papatsoris, I. Zachos & P.A. Konstantinopoulos:<br />
“Leiomyosarcoma of the prostate: case report and review of 54 previously<br />
published cases”. Sarcoma, 2008.<br />
72) P.A. Konstantinopoulos, M.V. <strong>Karamouzis</strong> & A.G. Papavassiliou: “Educational<br />
and Social-Ethical Issues in the Pursuit of Molecular Medicine”. Mol Med, 15: 60-<br />
63, 2009.<br />
73) Zachos I, Konstantinopoulos PA, Vandoros GP, <strong>Karamouzis</strong> MV, Papatsoris AG,<br />
Podimatas T, Papachristodoulou A, Chrisofos M, Deliveliotis C, Papavassiliou<br />
AG: “Predictive value of telomerase reverse transcriptase expression in patients<br />
with high risk superficial bladder cancer treated with adjuvant BCG<br />
immunotherapy”. J Cancer Res Clin Oncol, 135: 1169-75, 2009.<br />
74) M.V. <strong>Karamouzis</strong>, S. Moschos: “Endostatin in cancer therapeutics”, Expert Opin<br />
Biol Ther , 9: 641-648, 2009.<br />
75) D.E. Heron, R.L. Ferris, M.V. <strong>Karamouzis</strong>, R.S. Andrade, E.L. Deeb, S. Burton,<br />
W.E. Gooding, B.F. Branstetter, J.M. Mountz, J.T. Johnson, A. Argiris, J.R.<br />
Grandis, S.Y. Lai: „Stereotactic Body Radiotherapy for Recurrent Squamous Cell<br />
Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial”. Int<br />
J Radiat Oncol Biol Phys, 75: 1493-500, 2009.<br />
76) M.V. <strong>Karamouzis</strong>, P.A. Konstantinopoulos, A.G. Papavassiliou: “Targeting c-Met<br />
as a strategy to overcome cross-talk related resistance to EGFR protein -targeting<br />
agents in cancer therapeutics”, Lancet Oncol, 10: 709-77, 2009.<br />
77) A.G. Pallis, M.V. <strong>Karamouzis</strong>, P.A. Konstantinopoulos, A.G. Papavassiliou:<br />
“Moleular networks in respiratory epithelium carcinomas”, Cancer Lett, 95: 1-6,<br />
2010.<br />
78) I. Zachos, P.A. Konstantinopoulos, V. Tzortzis, S. Gravas, A. Karatzas, M.V.<br />
<strong>Karamouzis</strong>, M. Melekos, AG. Papavassiliou: “Systemic therapy of metastatic<br />
9<br />
9
Change language